{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:53:58Z","timestamp":1784919238941,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T00:00:00Z","timestamp":1200009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/sj.eye.6703078","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T10:58:22Z","timestamp":1200049102000},"page":"294-298","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of topical fixed-combination fortified vancomycin\u2013amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer"],"prefix":"10.1038","volume":"23","author":[{"given":"C-C","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-T","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-Y","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,11]]},"reference":[{"issue":"4 Suppl","key":"BF6703078_CR1","first-page":"34S","volume":"112","author":"HM Leibowitz","year":"1991","unstructured":"Leibowitz HM . Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991; 112 (4 Suppl): 34S\u201347S.","journal-title":"Am J Ophthalmol"},{"key":"BF6703078_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0002-9394(14)74449-6","volume":"115","author":"DJ Parks","year":"1993","unstructured":"Parks DJ, Abrams DA, Sarfarazi FA, Katz HR . Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993; 115: 471\u2013477.","journal-title":"Am J Ophthalmol"},{"key":"BF6703078_CR3","first-page":"1033","volume":"35","author":"MC Callegan","year":"1994","unstructured":"Callegan MC, Engel LS, Hill JM, O'Callaghan RJ . Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest Ophthalmol Vis Sci 1994; 35: 1033\u20131037.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6703078_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00003226-199413060-00006","volume":"13","author":"JP Guzek","year":"1994","unstructured":"Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM . Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Cornea 1994; 13: 500\u2013524.","journal-title":"Cornea"},{"key":"BF6703078_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00003226-199311000-00010","volume":"12","author":"MD Lauffenburger","year":"1993","unstructured":"Lauffenburger MD, Cohen KL . Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococus and Pseudomonas keratitis. Cornea 1993; 12: 517\u2013521.","journal-title":"Cornea"},{"key":"BF6703078_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0002-9394(14)70641-5","volume":"121","author":"KS Bower","year":"1996","unstructured":"Bower KS, Kowalski RP, Gordon YJ . Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996; 121: 712\u2013715.","journal-title":"Am J Ophthalmol"},{"key":"BF6703078_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","volume":"136","author":"RP Kowalski","year":"2003","unstructured":"Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003; 136: 500\u2013505.","journal-title":"Am J Ophthalmol"},{"key":"BF6703078_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archopht.121.9.1229","volume":"121","author":"KR Wilhelmus","year":"2003","unstructured":"Wilhelmus KR, Abshire RL, Schlech BA . Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis. Arch Ophthalmol 2003; 121: 1229\u20131233.","journal-title":"Arch Ophthalmol"},{"key":"BF6703078_CR9","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","volume":"106","author":"MH Goldstein","year":"1999","unstructured":"Goldstein MH, Kowalski RP, Gordon YJ . Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 1999; 106: 1313\u20131318.","journal-title":"Ophthalmology"},{"key":"BF6703078_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01.ico.0000134462.88535.d0","volume":"24","author":"E Aliprandis","year":"2005","unstructured":"Aliprandis E, Ciralsky J, Lai H, Herling I, Katz HR . Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. Cornea 2005; 24: 201\u2013205.","journal-title":"Cornea"},{"key":"BF6703078_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/01.ico.0000154231.10994.6d","volume":"24","author":"JM Lin","year":"2005","unstructured":"Lin JM, Tsai YY, Fu YL . The fixed combination of fortified vancomycin and amikacin ophthalmic solution\u2014VA solution: in vitro study of the potency and stability. Cornea 2005; 24: 717\u2013721.","journal-title":"Cornea"},{"key":"BF6703078_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1755-3768.1958.tb02281.x","volume":"36","author":"U Rexed","year":"1958","unstructured":"Rexed U . The pH of the lachrymal fluid determined by a capillary micro-glass electrode. Acta Ophthalmol 1958; 36: 711\u2013718.","journal-title":"Acta Ophthalmol"},{"key":"BF6703078_CR13","volume-title":"Ocular Therapeutics: Pharmacology and Clinical Application","author":"PU Fechner","year":"1998","unstructured":"Fechner PU, Teichmann KD . Ocular Therapeutics: Pharmacology and Clinical Application. Thorofare, NJ: Slack Inc., 1998."},{"issue":"5","key":"BF6703078_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ajo.2007.06.038","volume":"144","author":"CF Fong","year":"2007","unstructured":"Fong CF, Hu FR, Tseng CH, Wang IJ, Chen WL, Hou YC . Antibiotic susceptibility of bacterial isolates from bacterial keratitis cases in a university hospital in Taiwan. Am J Ophthalmol 2007; 144 (5): 682\u2013689.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"BF6703078_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/bjo.87.7.834","volume":"87","author":"T Bourcier","year":"2003","unstructured":"Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L . Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 2003; 87 (7): 834\u2013838.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"BF6703078_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/jop.2006.81","volume":"23","author":"P Bu","year":"2007","unstructured":"Bu P, Riske PS, Zaya NE, Carey R, Bouchard CS . A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin\/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. J Ocul Pharmacol Ther 2007; 23 (3): 213\u2013220.","journal-title":"J Ocul Pharmacol Ther"},{"key":"BF6703078_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.1977.03280100027017","volume":"238","author":"VL Yu","year":"1977","unstructured":"Yu VL, Rhame FS, Pesanti EL, Axline SG . Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms. JAMA 1977; 238: 943\u2013947.","journal-title":"JAMA"},{"issue":"2","key":"BF6703078_CR18","first-page":"109","volume":"50","author":"MJ Bharathi","year":"2002","unstructured":"Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R . In-vitro efficacy of antibacterials against bacterial isolates from corneal ulcers. Indian J Ophthalmol 2002; 50 (2): 109\u2013114.","journal-title":"Indian J Ophthalmol"},{"key":"BF6703078_CR19","first-page":"95","volume":"47","author":"S Sharma","year":"1999","unstructured":"Sharma S, Kunimoto DY, Garg P, Rao GN . Trends in antibiotic resistance of corneal pathogens: part I. An analysis of commonly used ocular antibiotics. Indian J Ophthalmol 1999; 47: 95\u2013100.","journal-title":"Indian J Ophthalmol"},{"key":"BF6703078_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2710.2005.00641.x","volume":"30","author":"MP Ventura","year":"2005","unstructured":"Ventura MP, Saheb NE, Solari HP, Saraiva VS, Vianna RN, Burnier Jr MN . Cost considerations of the new fixed combinations for glaucoma medical therapy. J Clin Pharm Ther 2005; 30: 251\u2013254.","journal-title":"J Clin Pharm Ther"},{"key":"BF6703078_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0039-6257(83)90142-X","volume":"28","author":"TJ Zimmerman","year":"1983","unstructured":"Zimmerman TJ, Zalta AH . Facilitating patient compliance in glaucoma therapy. Surv Ophthalmol 1983; 28: 252\u2013258.","journal-title":"Surv Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6703078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6703078","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6703078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:32:06Z","timestamp":1684413126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6703078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BF6703078"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6703078","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,11]]}}}